Protective effects of Kudiezi Oral Solution on experimental hyperlipoproteinemia in rats

刘冷,徐华丽,于晓风,曲绍春,梁启明,睢大员
DOI: https://doi.org/10.13481/j.1671-587x.2008.05.017
2008-01-01
Abstract:Objective To observe the effect of Kudiezi Oral Solution(KDZOS) on total cholesterol(TC),lipoprotein cholesterol metabolism and antioxidative activity in experimental hyperlipoproteinemia rats.Methods 60 Wistar rats were divided into 6 groups and each group had 10 rats.Control group was given normal food.The models of experimental hyperlipoproteinemia were established by giving lipid-riched feeds to Wistar rats for 15 d.The contents of TC,triglyceride(TG),high density lipoprotein cholesterol(HDL-C) and low density lipoprotein cholesterol(LDL-C) were measured and the atherogenic index(AI) was calculated.At the same time,the prostacycline(PGI2) and thromboxane(TXA2) levels in plasma,the malondialdehyde(MDA) contents and the superoxide dismutase(SOD) activities in serum and liver,and the viscosity of whole blood were also measured respectively in hyperlipidemia rats.In addition,the fat accumulation in liver was observed.Results In rats treated with KDZOS(with doses of 20 and 40 g·kg-1 i.g for 30 d),the levels of TC,TG,LDL-C,TC/HDL-C,LDL-C/HDL-C,AI,TXA2,MDA and the viscosity of whole blood were decreased significantly(P<0.05 or P<0.01),HDL-C,PGI2,PGI2/TXA2 and SOD were increased significantly(P<0.05 or P<0.01),meanwhile the fatty degeneration of hepatic cells was relieved.Conclusion KDZOS can adjust the blood lipid metabolism in hyperlipoproteinemia rats and restrain fatty deposition in liver.
What problem does this paper attempt to address?